International Approvals: Aptivus, Noxafil, Xolair
The EU has approved tipranavir 250-mg capsules (Aptivus), posaconazole oral suspension (Noxafil), and omalizumab subcutaneous injection (Xolair).Yael Waknine
Continue to International Approvals: Aptivus, Noxafil, Xolair on Medscape Medical News Headlines.
Medical Buzz delivers the most recent headlines from the medical world. Diseases, cures, accidents, medicin. Click below for more headlines ...
Medical buzz
